Aurora Cannabis Inc. R (21P.F)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in CAD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CAD m | - | - | - | - | - | - | 196 | - |
| Operating profit | CAD m | ||||||||
| Net profit | CAD m | - | - | - | - | - | - | -112 | - |
| EPS reported | CAD | ||||||||
| Operating cashflow per share | CAD | ||||||||
| Capex per share | CAD | ||||||||
| FCF per share | CAD | ||||||||
| Free cash flow | CAD m | ||||||||
| Net debt | CAD m | ||||||||
| Book value equity | CAD m | ||||||||
| Book value per share | CAD | ||||||||
| Number of shares | m | 61.68 | |||||||
| DPS (TTM paid) | CAD |
Financial summary
Financials in CAD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | |||||||
| P/B LTM | x | 0.64 | |||||||
| P/S LTM | x | 1.17 | |||||||
| P/FCF LTM | x | -6.64 | |||||||
| EV/EBITDA LTM | x | -3.62 | |||||||
| EV/Sales LTM | x | 0.84 | |||||||
| Earnings Yield LTM | % | -32.86% | |||||||
| FCF Yield | % | -11.30% | |||||||
| Quality | |||||||||
| ROE | % | -21.00% | |||||||
| ROIC | % | -15.55% | |||||||
| Operating margin | % | -29.66% | |||||||
| Gross margin | % | +32.08% | |||||||
| FCF/Sales | % | -17.57% | |||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | |||||||
| Sales Growth YoY | % | - | |||||||
| Net Income Growth YoY | % | - | |||||||
| FCF Growth | % | - | |||||||
| Operating Profit Growth | % | - | |||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | |||||||
| Dividend Growth | % | - | |||||||
| Payout Ratio | % | 0.00% | |||||||
| FCF/Debt | x | -2.73 | |||||||
| Net Debt/EBITDA | x | 1.43 | |||||||
| EBIT/Net interest | x | -17.97 | |||||||
| Net debt/market cap | % | +1.74% | |||||||
| Net debt/Equity | x | -0.24 | |||||||
| Gross debt/equity | x | 0.04 | |||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Aurora Cannabis Inc., together with its various subsidiaries, specializes in the cultivation, processing, and sale of cannabis and cannabis-derived products, catering to both Canadian and international consumers. The organization operates distinctively across two main divisions: Canadian Cannabis and Plant Propagation. Its product line extends from pharmaceutical-grade cannabis to a broad array of medical and recreational cannabis items. Additionally, the company is involved in the propagation of vegetables and ornamental plants. Specific offerings include fresh and dried cannabis, various oils, trim, concentrates, ingestible forms, capsules, vaporizable products, edibles, extracts, and topical solutions. Aurora Cannabis also delivers essential patient counseling and community outreach services. Its diverse brand collection encompasses domestic names like San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, alongside international labels such as Pedanios, Bidiol, IndiMed, and CraftPlant. Founded in 2013, the company's corporate headquarters are situated in Edmonton, Canada.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Aurora Cannabis Inc., together with its various subsidiaries, specializes in the cultivation, processing, and sale of cannabis and cannabis-derived products, catering to both Canadian and international consumers. The organization operates distinctively across two main divisions: Canadian Cannabis and Plant Propagation. Its product line extends from pharmaceutical-grade cannabis to a broad array of medical and recreational cannabis items. Additionally, the company is involved in the propagation of vegetables and ornamental plants. Specific offerings include fresh and dried cannabis, various oils, trim, concentrates, ingestible forms, capsules, vaporizable products, edibles, extracts, and topical solutions. Aurora Cannabis also delivers essential patient counseling and community outreach services. Its diverse brand collection encompasses domestic names like San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, alongside international labels such as Pedanios, Bidiol, IndiMed, and CraftPlant. Founded in 2013, the company's corporate headquarters are situated in Edmonton, Canada.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free